Plasmin therapy enhances mobilization of HPCs after G-CSF.

The role of proteinases in the mobilization of hematopoietic progenitor cells (HPCs) after granulocyte colony-stimulating factor (G-CSF) remains unclear. Here we report that genetic loss of the plasminogen activator inhibitor Pai-1 or of the plasmin inhibitor alpha2-antiplasmin increases HPC mobilization in response to G-CSF. Moreover, thrombolytic agents, such as tenecteplase and microplasmin, enhance HPC mobilization in mice and humans. Taken together, these findings identify a novel role for plasmin in augmenting HPC mobilization in response to G-CSF.

[1]  H. Nakauchi,et al.  The plasminogen fibrinolytic pathway is required for hematopoietic regeneration. , 2007, Cell stem cell.

[2]  R. Schwinger,et al.  Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction , 2007, Clinical Research in Cardiology.

[3]  J. Lévesque,et al.  Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilization , 2005, The Journal of experimental medicine.

[4]  N. Nagai,et al.  Comparative effects of microplasmin and tissue‐type plasminogen activator (tPA) on cerebral hemorrhage in a middle cerebral artery occlusion model in mice , 2004, Journal of thrombosis and haemostasis : JTH.

[5]  T. Betsuyaku,et al.  Characterization of hematopoietic progenitor mobilization in protease-deficient mice. , 2004, Blood.

[6]  J. Talmadge,et al.  Use of Matrix Metalloproteinase (MMP)‐9 Knockout Mice Demonstrates that MMP‐9 Activity Is not Absolutely Required for G‐CSF or Flt‐3 Ligand‐Induced Hematopoietic Progenitor Cell Mobilization or Engraftment , 2003, Stem cells.

[7]  R. Taichman,et al.  G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4 , 2002, Nature Immunology.

[8]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[9]  D. Link,et al.  Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor , 2002, Current opinion in hematology.

[10]  B. Williams,et al.  Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. , 2002, Experimental hematology.

[11]  P. Carmeliet,et al.  Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. , 1999, Circulation.

[12]  H. Lijnen,et al.  Characterization of the murine plasminogen/urokinase-type plasminogen-activator system. , 1996, European journal of biochemistry.

[13]  H. Lijnen,et al.  Characterization of the murine plasma fibrinolytic system. , 1994, European journal of biochemistry.

[14]  D. Botstein,et al.  A faster-acting and more potent form of tissue plasminogen activator. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L. Tavazzi,et al.  Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. , 2005, Blood.

[16]  D. Link,et al.  Stem cell mobilization. , 2003, Hematology. American Society of Hematology. Education Program.

[17]  D. Collen.  Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling. , 2001, Hematology. American Society of Hematology. Education Program.